CIPLA MALAYSIA SDN BHD — Salbutamol Importer Profile
Pharmaceutical Importer · #5 buyer for Salbutamol · $4.5M import value · 178 shipments · MALAYSIA · DGFT Verified
CIPLA MALAYSIA SDN BHD is the #5 importer of Salbutamol from India with $4.5M in import value and 178 verified shipments. CIPLA MALAYSIA SDN BHD holds a 2.6% market share in Salbutamol imports based in MALAYSIA. The company sources from 2 verified suppliers across 18 formulations shipped to 1 country. Overall, CIPLA MALAYSIA SDN BHD imports 2 pharmaceutical products worth $4.1M across 1 therapeutic categories.
CIPLA MALAYSIA SDN BHD — Salbutamol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Salbutamol to CIPLA MALAYSIA SDN BHD?
Verified from 178 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| MEDISPRAY LABORATORIES PRIVATE LIMITED | $4.2M | 159 | 92.5% |
| CIPLA LIMITED | $339.3K | 19 | 7.5% |
CIPLA MALAYSIA SDN BHD sources Salbutamol from 2 verified Indian suppliers based on 178 customs records. The primary supplier is MEDISPRAY LABORATORIES PRIVATE LIMITED accounting for 92.5% of imports.
How Does CIPLA MALAYSIA SDN BHD Compare to Nearest Salbutamol Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 3 | LABORATORIO TEUTO BRASILEIRO S A | BRAZIL | $8.3M | 294 | $28.1K |
| 4 | BREATHEFREE LANKA PVT LTD | SRI LANKA | $4.9M | 140 | $35.2K |
| 5 | CIPLA MALAYSIA SDN BHD ★ | MALAYSIA | $3.9M | 149 | $26.0K |
| 6 | PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR | TURKEY | $2.5M | 69 | $36.3K |
| 7 | ALLOGA UK LTD | UNITED KINGDOM | $2.5M | 88 | $28.4K |
CIPLA MALAYSIA SDN BHD ranks #5 among 1,775 Salbutamol importers from India. Average shipment value of $26.0K compared to the market average of $38.1K. The closest competitors by value are LABORATORIO TEUTO BRASILEIRO S A and BREATHEFREE LANKA PVT LTD.
Where Does CIPLA MALAYSIA SDN BHD Import Salbutamol To?
Destination countries from 178 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| MALAYSIA | $4.5M | 178 | 100.0% |
CIPLA MALAYSIA SDN BHD imports Salbutamol to 1 country. The primary destination is MALAYSIA receiving 100.0% of shipments worth $4.5M.
What Salbutamol Formulations Does CIPLA MALAYSIA SDN BHD Import?
| Formulation | Value | Shipments |
|---|---|---|
| ASTHALIN 100 MCG INHALER (SALBUTAMOL SUL | $1.7M | 50 |
| ASTHALIN 100MCG INHALER (SALBUTAMOL SULPHATE ) (1 X 200 MD) | $1.2M | 35 |
| ASTHALIN 100 MCG INHALER (SALBUTAMOL SULPHATE ) . | $660.3K | 47 |
| ASTHALIN 100 MCG INHALER SALBUTAMOL SULPHATE . | $310.5K | 10 |
| ASTHALIN 100 MCG INHALER SALBUTAMOL SUL | $141.0K | 8 |
| ASTHALIN 100 MCG INHALER (SALBUTAMOL SULPHATE ) (1 X 200 MD) . | $136.9K | 8 |
| DUOLIN RESPULES IPRATROPIUM BROMIDE 0 5MG SALBUTAMOL SULPHATE 2 5MG PER 2 5ML RESPULES 8000PACKx4X5 160000NUM 2 5ML | $50.0K | 1 |
| DUOLIN RESPULES IPRATROPIUM BROMIDE 0 5MG SALBUTAMOL SULPHATE 2 5 MG PER 2 5ML RESPULES INV QTY 10112 PACK 4X5X2 5M | $50.0K | 1 |
| DUOLIN RESPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML) RESPULES) (INV.QTY. 12800 PA | $50.0K | 1 |
| DUOLIN RESPULES (IPRATROPIUM BROMIDE 0.5MG+SALBUTAMOL SULPHATE 2.5MG(PER 2.5ML) RESPULES) ( INV.QTY.4992 PAC | $49.3K | 1 |
CIPLA MALAYSIA SDN BHD imports 18 distinct Salbutamol formulations from India. The top formulation is ASTHALIN 100 MCG INHALER (SALBUTAMOL SUL with 50 shipments worth $1.7M.
Who Are the Top Buyers of Salbutamol from India and How Much Does CIPLA MALAYSIA SDN BHD Import?
India exported $67.6M worth of Salbutamol through 14,359 shipments from 602 suppliers to 164 countries, serving 1,775 buyers globally. CIPLA MALAYSIA SDN BHD imports $4.5M of this total, accounting for 2.6% of India's Salbutamol exports with 178 shipments from MALAYSIA. This is verified from 178 customs shipment records covering 18 distinct formulations.
What Is the Average Order Value for CIPLA MALAYSIA SDN BHD's Salbutamol Imports?
CIPLA MALAYSIA SDN BHD's average Salbutamol order value is $25.3K per consignment, based on 178 shipments totaling $4.5M. CIPLA MALAYSIA SDN BHD is based in MALAYSIA and ranks #5 among all Salbutamol importers from India by value. The company sources from 2 verified suppliers in India.
Who Supplies Salbutamol to CIPLA MALAYSIA SDN BHD?
CIPLA MALAYSIA SDN BHD sources Salbutamol from 2 verified Indian suppliers: MEDISPRAY LABORATORIES PRIVATE LIMITED ($4.2M, 92.5%), CIPLA LIMITED ($339.3K, 7.5%). This is based on 178 customs records.
How Does CIPLA MALAYSIA SDN BHD Compare to Other Salbutamol Importers?
CIPLA MALAYSIA SDN BHD ranks #5 among 1,775 Salbutamol importers from India with a 2.6% market share. The top 3 importers are LABORATORIO TEUTO BRASILEIRO S/A ($23.9M), MEDPRO PHARMACEUTICA (PTY) LTD ($9.2M), LABORATORIO TEUTO BRASILEIRO S A ($8.3M). CIPLA MALAYSIA SDN BHD processed 178 shipments from MALAYSIA.
What Other Respiratory Products Does CIPLA MALAYSIA SDN BHD Import?
CIPLA MALAYSIA SDN BHD also imports these respiratory products. Each links to the detailed product page.
About CIPLA MALAYSIA SDN BHD
CIPLA MALAYSIA SDN BHD imports 2 products worth $4.1M. Beyond Salbutamol, top products include Ipratropium. View the complete CIPLA MALAYSIA SDN BHD profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Salbutamol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Salbutamol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CIPLA MALAYSIA SDN BHD matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CIPLA MALAYSIA SDN BHD's capped import value divided by total capped export value for Salbutamol across all Indian exporters.
- 5.Verified Records: This page is backed by 178 individual customs records matching CIPLA MALAYSIA SDN BHD importing Salbutamol, covering 18 formulations from 2 verified suppliers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 164+ countries, 1,775+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Salbutamol Import Data for CIPLA MALAYSIA SDN BHD
Access order-level details, pricing data, supplier connections, and competitive analysis for CIPLA MALAYSIA SDN BHD's Salbutamol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CIPLA MALAYSIA SDN BHD
Full Company Profile →
2 products · $4.1M total trade · 1 categories
CIPLA MALAYSIA SDN BHD × Salbutamol
Verified from customs records
Company Overview
Top Products by CIPLA MALAYSIA SDN BHD
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CIPLA MALAYSIA SDN BHD.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Salbutamol. For current order-level data, contact TransData Nexus.